CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients

References

• Resnick D, Pearson A, Krieger M. The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem Sci 1994; 19: 5–8
   PubMed Web of Science ®Google Scholar
• Boyse E A, Miyazawa M, Aoki T, Old L J. Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci 1968; 170: 175–193
   PubMed Web of Science ®Google Scholar
• Boumsell L, Bernard A, Lepage V, Degos L, Lemerle J, Dausset J. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol 1978; 8: 900–904
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982; 155: 623–628
   PubMed Web of Science ®Google Scholar
• Van de Velde H, von Hoegen I, Luo W, Parnes J R, Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991; 351: 662–665
   PubMed Web of Science ®Google Scholar
• Parnes J R, Pan C. CD72, a negative regulator of B-cell responsiveness. Immunol Rev 2000; 176: 75–85
   PubMed Web of Science ®Google Scholar
• Biancone L, Bowen M A, Lim A, Aruffo A, Andres G, Stamenkovic I. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med 1996; 184: 811–819
   PubMed Web of Science ®Google Scholar
• Bikah G, Lynd F M, Aruffo A A, Ledbetter J A, Bondada S. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Int Immunol 1998; 10: 1185–1196
   PubMedGoogle Scholar
• Pospisil R, Fitts M G, Mage R G. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. J Exp Med 1996; 184: 1279–1284
   PubMed Web of Science ®Google Scholar
• Pospisil R, Silverman G J, Marti G E, Aruffo A, Bowen M A, Mage R G. CD5 is A potential selecting ligand for B-cell surface immunoglobulin: a possible role in maintenance and selective expansion of normal and malignant B cells. Leuk Lymphoma 2000; 36: 353–365
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Ushiro H, Mitsuuchi Y, Suzuki S, Matsuda M, Matsuda Y, et al. Primary structure of human poly (ADP-ribose) synthetase as deduced from cDNA sequence. J Biol Chem 1987; 262: 15990–15997
   PubMed Web of Science ®Google Scholar
• Beyers A D, Spruyt L L, Williams A F. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci USA 1992; 89: 2945–2949
   PubMed Web of Science ®Google Scholar
• Lankester A C, van Schijndel G M, Cordell J L, van Noesel C J, van Lier R A. CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 1994; 24: 812–816
   PubMed Web of Science ®Google Scholar
• Ceuppens J L, Baroja M L. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J Immunol 1986; 137: 1816–1821
   PubMed Web of Science ®Google Scholar
• June C H, Rabinovitch P S, Ledbetter J A. CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol 1987; 138: 2782–2792
   PubMed Web of Science ®Google Scholar
• Imboden J B, June C H, McCutcheon M A, Ledbetter J A. Stimulation of CD5 enhances signal transduction by the T cell antigen receptor. J Clin Invest 1990; 85: 130–134
   Google Scholar
• Spertini F, Stohl W, Ramesh N, Moody C, Geha R S. Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol 1991; 146: 47–52
   PubMed Web of Science ®Google Scholar
• Tarakhovsky A, Kanner S B, Hombach J, Ledbetter J A, Muller W, Killeen N, et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 1995; 269: 535–537
   PubMed Web of Science ®Google Scholar
• Bikah G, Carey J, Ciallella J R, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996; 274: 1906–1909
   PubMed Web of Science ®Google Scholar
• Hippen K L, Tze L E, Behrens T W. CD5 maintains tolerance in anergic B cells. J Exp Med 2000; 191: 883–890
   PubMed Web of Science ®Google Scholar
• Sen G, Bikah G, Venkataraman C, Bondada S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol 1999; 29: 3319–3328
   PubMed Web of Science ®Google Scholar
• Perez-Villar J J, Whitney G S, Bowen M A, Hewgill D H, Aruffo A A, Kanner S B. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol 1999; 19: 2903–2912
   PubMed Web of Science ®Google Scholar
• Raman C, Kuo A, Deshane J, Litchfield D W, Kimberly R P. Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. J Biol Chem 1998; 273: 19183–19189
   PubMed Web of Science ®Google Scholar
• Simarro M, Calvo J, Vila J M, Places L, Padilla O, Alberola-Ila J, et al. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol 1999; 162: 5149–5155
   PubMed Web of Science ®Google Scholar
• Gringhuis S I, de Leij L F, Coffer P J, Vellenga E. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes. Mol Cell Biol 1998; 18: 1725–1735
   PubMed Web of Science ®Google Scholar
• Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052–1057
   PubMed Web of Science ®Google Scholar
• Cantor G H, Pritchard S M, Dequiedt F, Willems L, Kettmann R, Davis W C. CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis. J Virol 2001; 75: 1689–1696
   PubMed Web of Science ®Google Scholar
• Perez-Chacon G, Vargas J A, Jorda J, Morado M, Rosado S, Martin-Donaire T, et al. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC. Leuk Res May 23, 2006, [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M, et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 1996; 88: 1365–1374
   PubMed Web of Science ®Google Scholar
• Zupo S, Massara R, Dono M, Rossi E, Malavasi F, Cosulich M E, et al. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood 2000; 95: 1199–1206
   Google Scholar
• Bernal A, Pastore R D, Asgary Z, Keller S A, Cesarman E, Liou H C, et al. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 2001; 98: 3050–3057
   PubMed Web of Science ®Google Scholar
• Damle R N, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S L, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Chen L, Widhopf G, Huynh L, Rassenti L, Rai K R, Weiss A, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002; 100: 4609–4614
   PubMed Web of Science ®Google Scholar
• Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F K, Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 2002; 101: 1087–1093
   PubMed Web of Science ®Google Scholar
• Fluckiger A C, Rossi J F, Bussel A, Bryon P, Banchereau J, Defrance T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173–3181
   PubMed Web of Science ®Google Scholar
• Silverman G J, Good year C S. A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol 2002; 102: 117–134
   PubMed Web of Science ®Google Scholar
• Contri A, Brunati A M, Trentin L, Cabrelle A, Miorin M, Cesaro L, et al. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 2005; 115: 369–378
   PubMed Web of Science ®Google Scholar
• Pers J O, Jamin C, Le Corre R, Lydyard P M, Youinou P. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis. Eur J Immunol 1998; 28: 4170–4176
   PubMed Web of Science ®Google Scholar
• Jamin C, Le Corre R, Lydyard P M, Youinou P. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2. Eur J Immunol 1996; 26: 57–62
   PubMed Web of Science ®Google Scholar
• Tarakhovsky A, Turner M, Schaal S, Mee P J, Duddy L P, Rajewsky K, et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995; 374: 467–470
   PubMedGoogle Scholar
• Chiorazzi N, Rai K R, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815
   PubMed Web of Science ®Google Scholar
• Renaudineau Y, Nedellec S, Berthou C, Lydyard P M, Youinou P, Pers J O. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells. Leukemia 2005; 19: 223–229
   PubMed Web of Science ®Google Scholar
• Schmid C, Isaacson P G. Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study. Histopathology 1994; 24: 445–451
   PubMed Web of Science ®Google Scholar
• Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 2777–2783
   PubMed Web of Science ®Google Scholar
• Damle R N, Batliwalla F M, Ghiotto F, Valetto A, Albesiano E, Sison C, et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004; 103: 375–382
   PubMed Web of Science ®Google Scholar